Per Stirling Capital Management’s Amgen AMGN Stock Holding History

Per Stirling Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$242K	Buy	687 +13	+2%	+$4.63K	0.03%	283
2025 Q4	$221K	Buy	+674	New	+$214K	0.02%	284
2024 Q4	–	Sell	-1,180	Closed	-$380K	–	257
2024 Q3	$380K	Buy	1,180 +33	+3%	+$10.8K	0.05%	206
2024 Q2	$358K	Sell	1,147 -24	-2%	-$7.05K	0.06%	188
2024 Q1	$333K	Buy	1,171 +24	+2%	+$7.02K	0.06%	181
2023 Q4	$330K	Buy	1,147 +140	+14%	+$38.1K	0.06%	165
2023 Q3	$271K	Sell	1,007 -14	-1%	-$3.49K	0.06%	170
2023 Q2	$227K	Buy	1,021 +61	+6%	+$14.2K	0.05%	180
2023 Q1	$232K	Hold	960	–	–	0.05%	168
2022 Q4	$252K	Buy	+960	New	+$257K	0.05%	179

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Per Stirling Capital Management's AMGN Position: Q1 2026 in Review

Per Stirling Capital Management increased its Amgen (AMGN) stake by 1.9% in Q1 2026, buying an estimated $4.63K and bringing the position to 687 shares worth $242K. The position accounts for 0.03% of the portfolio, ranked #283.

Per Stirling Capital Management first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. The position peaked at $380K in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Per Stirling Capital Management held 687 shares of Amgen worth $242K as of Q1 2026.
Per Stirling Capital Management bought 13 Amgen shares in Q1 2026, an estimated $4.63K.
Amgen made up 0.03% of Per Stirling Capital Management's portfolio in Q1 2026, its #283 holding.
Per Stirling Capital Management first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
Per Stirling Capital Management's Amgen position peaked at $380K in Q3 2024.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Per Stirling Capital Management's 13F filing for Q1 2026, filed 12 May 2026.